Over the past decade, contract manufacturing has rapidly gained popularity, particularly in the pharmaceutical and biotechnology industries. As a result, Contract Manufacturing Organizations (CMOs) have become an integral part of the supply chain. The global pharmaceutical CMO market was valued at USD 134.12 billion in 2021 and is expected to reach USD 204.14 billion by 2027, with a compound annual growth rate (CAGR) of 6.64 percent from 2022 to 2027.
Many pharmaceutical companies are now recognizing the potential profitability of working with a CMO for both clinical and commercial-stage manufacturing. This is mainly due to the increasing demand for generic medications and biologics, the capital-intensive nature of the industry, and the complex manufacturing requirements.
One of the significant factors driving the growth of CMOs in the pharmaceutical industry is the need for state-of-the-art processes and production technologies. These technologies have proven to be significantly effective in meeting regulatory requirements, which is becoming increasingly important as the industry becomes more heavily regulated. Therefore, partnering with a CMO can help pharmaceutical companies stay competitive and compliant while focusing on their core competencies.
In this edition of Pharma Tech Outlook, we present some of the most promising Contract Manufacturing Organizations along with thought leadership articles from Yvonne Ware, Associate Director, Manufacturing Operations at BioNTech SE, Max Brescia, Senior Global Director, Contract Manufacturing at AbbVie and Franck A. Vendeix, PhD, Associate Director, Analytical Services, AMRI (now Curia).
The magazine highlights BioSpectra, a leader in producing pharmaceutical-grade ingredients, including biological buffers, actives, excipients, GMP process chemicals, and new chemical entities (NCEs) at ICH Q7 levels. The publication also features other companies including Dipharma, a global Contract Development and Manufacturing Organisation (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients.
Leafing through these pages will give you comprehensive insights into the innovative trends and latest developments in the CMO landscape.


-(2)-1.jpg)











